Cargando…

A Pipeline for Predicting the Treatment Response of Neoadjuvant Chemoradiotherapy for Locally Advanced Rectal Cancer Using Single MRI Modality: Combining Deep Segmentation Network and Radiomics Analysis Based on “Suspicious Region”

Patients with locally advanced rectal cancer (LARC) who achieve a pathologic complete response (pCR) after neoadjuvant chemoradiotherapy (nCRT) typically have a good prognosis. An early and accurate prediction of the treatment response, i.e., whether a patient achieves pCR, could significantly help...

Descripción completa

Detalles Bibliográficos
Autores principales: Pang, Xiaolin, Wang, Fang, Zhang, Qianru, Li, Yan, Huang, Ruiyan, Yin, Xinke, Fan, Xinjuan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8371269/
https://www.ncbi.nlm.nih.gov/pubmed/34422664
http://dx.doi.org/10.3389/fonc.2021.711747
_version_ 1783739606919806976
author Pang, Xiaolin
Wang, Fang
Zhang, Qianru
Li, Yan
Huang, Ruiyan
Yin, Xinke
Fan, Xinjuan
author_facet Pang, Xiaolin
Wang, Fang
Zhang, Qianru
Li, Yan
Huang, Ruiyan
Yin, Xinke
Fan, Xinjuan
author_sort Pang, Xiaolin
collection PubMed
description Patients with locally advanced rectal cancer (LARC) who achieve a pathologic complete response (pCR) after neoadjuvant chemoradiotherapy (nCRT) typically have a good prognosis. An early and accurate prediction of the treatment response, i.e., whether a patient achieves pCR, could significantly help doctors make tailored plans for LARC patients. This study proposes a pipeline of pCR prediction using a combination of deep learning and radiomics analysis. Taking into consideration missing pre-nCRT magnetic resonance imaging (MRI), as well as aiming to improve the efficiency for clinical application, the pipeline only included a post-nCRT T2-weighted (T2-w) MRI. Unlike other studies that attempted to carefully find the region of interest (ROI) using a pre-nCRT MRI as a reference, we placed the ROI on a “suspicious region”, which is a continuous area that has a high possibility to contain a tumor or fibrosis as assessed by radiologists. A deep segmentation network, termed the two-stage rectum-aware U-Net (tsraU-Net), is designed to segment the ROI to substitute for a time-consuming manual delineation. This is followed by a radiomics analysis model based on the ROI to extract the hidden information and predict the pCR status. The data from a total of 275 patients were collected from two hospitals and partitioned into four datasets: Seg-T (N = 88) for training the tsraUNet, Rad-T (N = 107) for building the radiomics model, In-V (N = 46) for internal validation, and Ex-V (N = 34) for external validation. The proposed method achieved an area under the curve (AUC) of 0.829 (95% confidence interval [CI]: 0.821, 0.837) on In-V and 0.815 (95% CI, 0.801, 0.830) on Ex-V. The performance of the method was considerable and stable in two validation sets, indicating that the well-designed pipeline has the potential to be used in real clinical procedures.
format Online
Article
Text
id pubmed-8371269
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-83712692021-08-19 A Pipeline for Predicting the Treatment Response of Neoadjuvant Chemoradiotherapy for Locally Advanced Rectal Cancer Using Single MRI Modality: Combining Deep Segmentation Network and Radiomics Analysis Based on “Suspicious Region” Pang, Xiaolin Wang, Fang Zhang, Qianru Li, Yan Huang, Ruiyan Yin, Xinke Fan, Xinjuan Front Oncol Oncology Patients with locally advanced rectal cancer (LARC) who achieve a pathologic complete response (pCR) after neoadjuvant chemoradiotherapy (nCRT) typically have a good prognosis. An early and accurate prediction of the treatment response, i.e., whether a patient achieves pCR, could significantly help doctors make tailored plans for LARC patients. This study proposes a pipeline of pCR prediction using a combination of deep learning and radiomics analysis. Taking into consideration missing pre-nCRT magnetic resonance imaging (MRI), as well as aiming to improve the efficiency for clinical application, the pipeline only included a post-nCRT T2-weighted (T2-w) MRI. Unlike other studies that attempted to carefully find the region of interest (ROI) using a pre-nCRT MRI as a reference, we placed the ROI on a “suspicious region”, which is a continuous area that has a high possibility to contain a tumor or fibrosis as assessed by radiologists. A deep segmentation network, termed the two-stage rectum-aware U-Net (tsraU-Net), is designed to segment the ROI to substitute for a time-consuming manual delineation. This is followed by a radiomics analysis model based on the ROI to extract the hidden information and predict the pCR status. The data from a total of 275 patients were collected from two hospitals and partitioned into four datasets: Seg-T (N = 88) for training the tsraUNet, Rad-T (N = 107) for building the radiomics model, In-V (N = 46) for internal validation, and Ex-V (N = 34) for external validation. The proposed method achieved an area under the curve (AUC) of 0.829 (95% confidence interval [CI]: 0.821, 0.837) on In-V and 0.815 (95% CI, 0.801, 0.830) on Ex-V. The performance of the method was considerable and stable in two validation sets, indicating that the well-designed pipeline has the potential to be used in real clinical procedures. Frontiers Media S.A. 2021-08-04 /pmc/articles/PMC8371269/ /pubmed/34422664 http://dx.doi.org/10.3389/fonc.2021.711747 Text en Copyright © 2021 Pang, Wang, Zhang, Li, Huang, Yin and Fan https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Oncology
Pang, Xiaolin
Wang, Fang
Zhang, Qianru
Li, Yan
Huang, Ruiyan
Yin, Xinke
Fan, Xinjuan
A Pipeline for Predicting the Treatment Response of Neoadjuvant Chemoradiotherapy for Locally Advanced Rectal Cancer Using Single MRI Modality: Combining Deep Segmentation Network and Radiomics Analysis Based on “Suspicious Region”
title A Pipeline for Predicting the Treatment Response of Neoadjuvant Chemoradiotherapy for Locally Advanced Rectal Cancer Using Single MRI Modality: Combining Deep Segmentation Network and Radiomics Analysis Based on “Suspicious Region”
title_full A Pipeline for Predicting the Treatment Response of Neoadjuvant Chemoradiotherapy for Locally Advanced Rectal Cancer Using Single MRI Modality: Combining Deep Segmentation Network and Radiomics Analysis Based on “Suspicious Region”
title_fullStr A Pipeline for Predicting the Treatment Response of Neoadjuvant Chemoradiotherapy for Locally Advanced Rectal Cancer Using Single MRI Modality: Combining Deep Segmentation Network and Radiomics Analysis Based on “Suspicious Region”
title_full_unstemmed A Pipeline for Predicting the Treatment Response of Neoadjuvant Chemoradiotherapy for Locally Advanced Rectal Cancer Using Single MRI Modality: Combining Deep Segmentation Network and Radiomics Analysis Based on “Suspicious Region”
title_short A Pipeline for Predicting the Treatment Response of Neoadjuvant Chemoradiotherapy for Locally Advanced Rectal Cancer Using Single MRI Modality: Combining Deep Segmentation Network and Radiomics Analysis Based on “Suspicious Region”
title_sort pipeline for predicting the treatment response of neoadjuvant chemoradiotherapy for locally advanced rectal cancer using single mri modality: combining deep segmentation network and radiomics analysis based on “suspicious region”
topic Oncology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8371269/
https://www.ncbi.nlm.nih.gov/pubmed/34422664
http://dx.doi.org/10.3389/fonc.2021.711747
work_keys_str_mv AT pangxiaolin apipelineforpredictingthetreatmentresponseofneoadjuvantchemoradiotherapyforlocallyadvancedrectalcancerusingsinglemrimodalitycombiningdeepsegmentationnetworkandradiomicsanalysisbasedonsuspiciousregion
AT wangfang apipelineforpredictingthetreatmentresponseofneoadjuvantchemoradiotherapyforlocallyadvancedrectalcancerusingsinglemrimodalitycombiningdeepsegmentationnetworkandradiomicsanalysisbasedonsuspiciousregion
AT zhangqianru apipelineforpredictingthetreatmentresponseofneoadjuvantchemoradiotherapyforlocallyadvancedrectalcancerusingsinglemrimodalitycombiningdeepsegmentationnetworkandradiomicsanalysisbasedonsuspiciousregion
AT liyan apipelineforpredictingthetreatmentresponseofneoadjuvantchemoradiotherapyforlocallyadvancedrectalcancerusingsinglemrimodalitycombiningdeepsegmentationnetworkandradiomicsanalysisbasedonsuspiciousregion
AT huangruiyan apipelineforpredictingthetreatmentresponseofneoadjuvantchemoradiotherapyforlocallyadvancedrectalcancerusingsinglemrimodalitycombiningdeepsegmentationnetworkandradiomicsanalysisbasedonsuspiciousregion
AT yinxinke apipelineforpredictingthetreatmentresponseofneoadjuvantchemoradiotherapyforlocallyadvancedrectalcancerusingsinglemrimodalitycombiningdeepsegmentationnetworkandradiomicsanalysisbasedonsuspiciousregion
AT fanxinjuan apipelineforpredictingthetreatmentresponseofneoadjuvantchemoradiotherapyforlocallyadvancedrectalcancerusingsinglemrimodalitycombiningdeepsegmentationnetworkandradiomicsanalysisbasedonsuspiciousregion
AT pangxiaolin pipelineforpredictingthetreatmentresponseofneoadjuvantchemoradiotherapyforlocallyadvancedrectalcancerusingsinglemrimodalitycombiningdeepsegmentationnetworkandradiomicsanalysisbasedonsuspiciousregion
AT wangfang pipelineforpredictingthetreatmentresponseofneoadjuvantchemoradiotherapyforlocallyadvancedrectalcancerusingsinglemrimodalitycombiningdeepsegmentationnetworkandradiomicsanalysisbasedonsuspiciousregion
AT zhangqianru pipelineforpredictingthetreatmentresponseofneoadjuvantchemoradiotherapyforlocallyadvancedrectalcancerusingsinglemrimodalitycombiningdeepsegmentationnetworkandradiomicsanalysisbasedonsuspiciousregion
AT liyan pipelineforpredictingthetreatmentresponseofneoadjuvantchemoradiotherapyforlocallyadvancedrectalcancerusingsinglemrimodalitycombiningdeepsegmentationnetworkandradiomicsanalysisbasedonsuspiciousregion
AT huangruiyan pipelineforpredictingthetreatmentresponseofneoadjuvantchemoradiotherapyforlocallyadvancedrectalcancerusingsinglemrimodalitycombiningdeepsegmentationnetworkandradiomicsanalysisbasedonsuspiciousregion
AT yinxinke pipelineforpredictingthetreatmentresponseofneoadjuvantchemoradiotherapyforlocallyadvancedrectalcancerusingsinglemrimodalitycombiningdeepsegmentationnetworkandradiomicsanalysisbasedonsuspiciousregion
AT fanxinjuan pipelineforpredictingthetreatmentresponseofneoadjuvantchemoradiotherapyforlocallyadvancedrectalcancerusingsinglemrimodalitycombiningdeepsegmentationnetworkandradiomicsanalysisbasedonsuspiciousregion